Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 10, 2019 Off

Frelii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment

By BusinessWire

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTC PINK: FRLI) (“Frelii” or “the Company”) today announced the details of its recent agreement with…

June 10, 2019 Off

Global $17.1Bn Leukemia Therapeutics Market Forecast to 2024: Focus on CLL, ALL, CML, AML – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration…

June 10, 2019 Off

Global Microbiome Partnering Terms and Agreements 2014-2019: Disclosed Headlines, Upfronts, Milestones and Royalties by Stage of Development – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Microbiome Partnering Terms and Agreements 2014 to 2019” report has been added to ResearchAndMarkets.com’s offering. The Global…

June 10, 2019 Off

Janssen to Present Data from its Robust Oncology Portfolio and Pipeline at the 24th EHA Annual Congress

By BusinessWire

Results from DARZALEX® ▼ (daratumumab) Phase 3 CASSIOPEIA study in newly diagnosed transplant eligible patients with multiple myeloma selected for…

June 10, 2019 Off

Dr. Reddy’s Laboratories Limited Through Its Wholly Owned Subsidiary, Dr. Reddy’s Laboratories SA, Announces Positive Topline Results from Phase 2b Study of PPC-06 in Patients with Moderate to Severe Plaque Psoriasis

By BusinessWire

HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as…

June 10, 2019 Off

nference Enters into an R&D Data Science Strategic Partnership with Janssen

By BusinessWire

Multi-year research collaboration and software agreement reimagines the discovery and clinical development of medicines through data sciences CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference,…

June 10, 2019 Off

Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes

By BusinessWire

Pediatric Scientific Data for the Omnipod Horizon System Presented at the American Diabetes Association’s 79th Scientific Sessions ACTON, Mass.–(BUSINESS WIRE)–Insulet…

June 10, 2019 Off

Acucela Receives Orphan Designation From the EMA for Emixustat for the Treatment of Stargardt Disease

By BusinessWire

SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced…

June 9, 2019 Off

Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…

June 9, 2019 Off

Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…

Posts pagination

Previous 1 … 3,115 3,116 3,117 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine